Obsessive-compulsive symptoms in adjunctive therapy with lamotrigine in clozapine-medicated patients

Schizophrenia Research

Volumn 166, Issue 1-3, 2015, Pages 364-365

  Szmulewicz, Alejandro G ^a   Valerio, Marina P ^a   Smith, José M ^a  

^a Hospital Alvear   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LAMOTRIGINE; NEUROLEPTIC AGENT; TRIAZINE DERIVATIVE;

ADJUVANT THERAPY; ADULT; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; YALE BROWN OBSESSIVE COMPULSIVE SCALE; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; CROSS-SECTIONAL STUDY; OBSESSIVE-COMPULSIVE DISORDER; PREVALENCE; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS; RISK;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA; TRIAZINES;

EID: 84946471231     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.05.035     Document Type: Letter

References (11)

1. Alkin T., Onur E., Ozerdem A. Co-occurence of blepharospasm, tourettism and obsessive-compulsive symptoms during lamotrigine treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31(6):1339-1340. (Aug 15).
2. Cunill R., Castells X., Simeon D. Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J. Clin. Psychiatry 2009, 70(1):70-82. (Jan).
3. Kemp D.E., Gilmer W.S., Fleck J., Dago P.L. An association of intrusive, repetitive phrases with lamotrigine treatment in bipolar II disorder. CNS Spectr. 2007, 12(2):106-111. (Feb).
4. Kuloglu M., Caykoylu A., Ekinci O., Yilmaz E. Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report. J. Psychopharmacol. 2009, 23(8):1001-1003. (Nov).
5. Lee S.A., Lee H.W., Heo K., Shin D.J., Song H.K., Kim O.J., Lee S.M., Kim S.O., Lee B.I. Cognitive and behavioral effects of lamotrigine and carbamazepine monotherapy in patients with newly diagnosed or untreated partial epilepsy. Seizure 2011, 20(1):49-54. (Jan).
6. Lykouras L., Alevizos B., Michalopoulou P., Rabavilas A. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27(3):333-346. (May).
7. Mahendran R., Liew E., Subramaniam M. De novo emergence of obsessive-compulsive symptoms with atypical antipsychotics in Asian patients with schizophrenia or schizoaffective disorder: a retrospective, cross-sectional study. J. Clin. Psychiatry 2007, 68(4):542-545. (Apr).
8. Schirmbeck F., Esslinger C., Rausch F., Englisch S., Meyer-Lindenberg A., Zink M. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol. Med. 2011, 41(11):2361-2373. (Nov).
9. Schirmbeck F., Rausch F., Englisch S., Eifler S., Esslinger C., Meyer-Lindenberg A., Zink M. Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study. J. Psychopharmacol. 2013, 27(4):349-357. (Apr).
10. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The MINI International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33.
11. Tiihonen J., Wahlbeck K., Kiviniemi V. The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis. Schizophr. Res. 2009, 109(1-3):10-14. (Apr).